×
About 2,829 results

ALLMedicine™ Hirsutism Center

Research & Reviews  1,293 results

Metabolomic Biomarkers in Polycystic Ovary Syndrome: A Review of the Evidence.
https://doi.org/10.1055/s-0041-1729841
Seminars in Reproductive Medicine; Alesi S, Ghelani D et. al.

May 4th, 2021 - Polycystic ovary syndrome (PCOS) is an endocrinologic condition affecting one in five women of reproductive age. PCOS is often characterized by disruptions to the menstrual cycle, development of male-pattern hair growth (hirsutism), and polycystic...

The way toward adulthood for females with nonclassic congenital adrenal hyperplasia.
https://doi.org/10.1007/s12020-021-02715-z 10.1016/j.ymgme.2006.12.005 10.1038/gim.2017.46 10.1093/humupd/dmx014 10.1038/s41431-020-0653-5 10.1210/jc.2006-1645 10.1073/pnas.1300057110 10.1530/eje.0.1430397 10.1530/EC-18-0281 10.1210/jcem.86.1.7131 10.1210/jc.2008-1582 10.1055/s-0032-1330007 10.3390/ijms21134622 10.1530/EJE-20-0129 10.1016/j.mce.2016.08.014 10.1210/jc.2018-02605 10.1111/cen.12543 10.1067/mob.2000.108020 10.1210/jc.2018-01865 10.1152/physrev.00033.2015 10.1677/jme.0.0270249 10.1016/S0047-6374(01)00394-3 10.3275/7410 10.4158/EP-2018-0617 10.1159/000337217 10.1530/EJE-11-0119 10.1159/000509079 10.1530/eje.0.1360188 10.1111/apa.12147 10.1515/jpem.2007.20.8.883 10.1515/jpem-2017-0088 10.3275/8194 10.1210/jc.2012-2102 10.1530/EJE-13-0128 10.1210/jc.2002-021433 10.1159/000053253 10.1111/j.1365-2265.1995.tb01890.x 10.1111/cen.12507 10.1210/jc.2007-0744 10.1016/8756-3282(96)00003-8 10.1007/s12020-014-0332-9 10.1111/cen.14149 10.1530/EJE-07-0887 10.1159/000098017 10.1530/EJE-15-1096 10.1136/jim-2016-000085 10.1210/jc.2006-0062 10.1055/s-0034-1389901 10.1046/j.1365-2265.2000.00995.x 10.1111/nyas.13370 10.4158/EP15748.DSCPT2 10.1210/jcem-70-3-642 10.1210/jc.2009-1383 10.1210/jcem.74.3.1310999 10.1210/en.2019-00101 10.1111/jog.13288 10.1093/humrep/del284 10.1093/humrep/der126 10.1111/j.1365-2265.2009.03563.x 10.1530/EJE-11-0019 10.1530/EC-17-0094 10.1210/jc.2009-2639 10.1093/humrep/den118 10.1055/s-0035-1565183 10.1111/j.1365-2265.2010.03920.x 10.1111/cen.13429 10.1210/JC.2015-2093 10.1210/jc.2014-2957 10.4103/2230-8210.102995 10.1210/jc.2010-0917 10.1507/endocrj.51.601 10.1080/00015385.2019.1666964 10.1016/j.pharep.2019.01.014 10.1055/s-0035-1569375 10.1210/jcem.75.6.1464643 10.1159/000086363 10.1055/s-0034-1382048 10.1210/jcem.74.3.1311000 10.1055/s-0035-1549911 10.4158/EP151085.RA 10.1515/JPEM.2001.14.4.415 10.1210/jc.2014-1342 10.1159/000369901 10.1515/jpem-2016-0216 10.1210/jc.2018-00208 10.4158/EP-2019-0509 10.1007/s11136-019-02350-2 10.1007/s10508-006-9068-9 10.1007/s10508-016-0693-7 10.1016/j.jsxm.2015.11.002 10.1210/jc.2007-0556 10.1016/j.jsxm.2019.07.009 10.1016/j.psyneuen.2015.06.017 10.1210/js.2019-00122
Endocrine Ntali G, Charisis S et. al.

Apr 15th, 2021 - Females with NC21OHD may present as asymptomatic or develop a wide range of androgen excess expression. Clinical manifestations may become evident in childhood and adolescence and include premature pubarche, precocious puberty, acne, hirsutism, an...

Delayed Identification of Adolescent Adrenal Cortical Carcinoma Initially Diagnosed as ...
https://doi.org/10.1016/j.jpag.2021.03.004
Journal of Pediatric and Adolescent Gynecology; Ziqin L, Yurui W et. al.

Mar 29th, 2021 - Adrenocortical carcinoma is a rare, isolated malignancy. A 13-year-old girl presented with secondary amenorrhea, hirsutism, and hypertension. Her clinical manifestations were interpreted as polycystic ovary syndrome and hyperinsulinemia. The rapid...

Galanin and glypican-4 levels depending on metabolic and cardiovascular risk factors in...
https://doi.org/10.20945/2359-3997000000340
Archives of Endocrinology and Metabolism; Altinkaya SO

Mar 19th, 2021 - Galanin is a neuropeptide which has effects not only on metabolic syndrome but also on reproduction. Glypican-4 is an adipokine associated with insulin sensitivity by interacting directly with the insulin receptor. This study evaluated serum conce...

Ovarian Leydig cell tumor and postmenopausal hirsutism with signs of virilisation.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978078
BMJ Case Reports; Ferrinho C, Silva E et. al.

Mar 18th, 2021 - A 71-year-old woman was referred to the endocrinology clinic to investigate postmenopausal hirsutism with 10 years of evolution. She had history of regular menses and menopause with 50 years old. Physical examination showed a male pattern facies, ...

see more →

Guidelines  15 results

Screening and Management of the Hyperandrogenic Adolescent
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Adolescent-Health-Care/Screening-and-Management-of-the-Hyperandrogenic-Adolescent

Sep 23rd, 2019 - Although androgen excess can manifest in many ways, the most common and recognizable symptoms are hirsutism and acne. Reports of hirsutism and acne should be taken seriously because of their possible association with medical disorders, their subst...

Hirsutism in Women
https://www.aafp.org/afp/2019/0801/p168.html

Jul 31st, 2019 - Hirsutism is the excessive growth of terminal hair in a typical male pattern in a female. It is often a sign of excessive androgen levels. Although many conditions can lead to hirsutism, polycystic ovary syndrome and idiopathic hyperandrogenism ac...

Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical ...
https://academic.oup.com/jcem/article/103/4/1233/4924418
Kathryn A. Martin

Mar 31st, 2018 - We suggest testing for elevated androgen levels in all women with an abnormal hirsutism score. We suggest against testing for elevated androgen levels in eumenorrheic women with unwanted local hair growth (i.

Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clin...
https://doi.org/10.1210/jc.2018-00241
The Journal of Clinical Endocrinology and Metabolism; Martin KA, Anderson RR et. al.

Mar 9th, 2018 - To update the "Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline," published by the Endocrine Society in 2008. The participants include an Endocrine Society-appointed task force of seven...

No. 350-Hirsutism: Evaluation and Treatment.
https://doi.org/10.1016/j.jogc.2017.05.022
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Liu K, Motan T et. al.

Oct 30th, 2017 - To review the etiology, evaluation, and treatment of hirsutism. A thorough history and physical examination plus selected laboratory evaluations will confirm the diagnosis and direct treatment. Pharmacologic interventions can suppress ovarian or a...

see more →

Clinicaltrials.gov  1,387 results

Metabolomic Biomarkers in Polycystic Ovary Syndrome: A Review of the Evidence.
https://doi.org/10.1055/s-0041-1729841
Seminars in Reproductive Medicine; Alesi S, Ghelani D et. al.

May 4th, 2021 - Polycystic ovary syndrome (PCOS) is an endocrinologic condition affecting one in five women of reproductive age. PCOS is often characterized by disruptions to the menstrual cycle, development of male-pattern hair growth (hirsutism), and polycystic...

The way toward adulthood for females with nonclassic congenital adrenal hyperplasia.
https://doi.org/10.1007/s12020-021-02715-z 10.1016/j.ymgme.2006.12.005 10.1038/gim.2017.46 10.1093/humupd/dmx014 10.1038/s41431-020-0653-5 10.1210/jc.2006-1645 10.1073/pnas.1300057110 10.1530/eje.0.1430397 10.1530/EC-18-0281 10.1210/jcem.86.1.7131 10.1210/jc.2008-1582 10.1055/s-0032-1330007 10.3390/ijms21134622 10.1530/EJE-20-0129 10.1016/j.mce.2016.08.014 10.1210/jc.2018-02605 10.1111/cen.12543 10.1067/mob.2000.108020 10.1210/jc.2018-01865 10.1152/physrev.00033.2015 10.1677/jme.0.0270249 10.1016/S0047-6374(01)00394-3 10.3275/7410 10.4158/EP-2018-0617 10.1159/000337217 10.1530/EJE-11-0119 10.1159/000509079 10.1530/eje.0.1360188 10.1111/apa.12147 10.1515/jpem.2007.20.8.883 10.1515/jpem-2017-0088 10.3275/8194 10.1210/jc.2012-2102 10.1530/EJE-13-0128 10.1210/jc.2002-021433 10.1159/000053253 10.1111/j.1365-2265.1995.tb01890.x 10.1111/cen.12507 10.1210/jc.2007-0744 10.1016/8756-3282(96)00003-8 10.1007/s12020-014-0332-9 10.1111/cen.14149 10.1530/EJE-07-0887 10.1159/000098017 10.1530/EJE-15-1096 10.1136/jim-2016-000085 10.1210/jc.2006-0062 10.1055/s-0034-1389901 10.1046/j.1365-2265.2000.00995.x 10.1111/nyas.13370 10.4158/EP15748.DSCPT2 10.1210/jcem-70-3-642 10.1210/jc.2009-1383 10.1210/jcem.74.3.1310999 10.1210/en.2019-00101 10.1111/jog.13288 10.1093/humrep/del284 10.1093/humrep/der126 10.1111/j.1365-2265.2009.03563.x 10.1530/EJE-11-0019 10.1530/EC-17-0094 10.1210/jc.2009-2639 10.1093/humrep/den118 10.1055/s-0035-1565183 10.1111/j.1365-2265.2010.03920.x 10.1111/cen.13429 10.1210/JC.2015-2093 10.1210/jc.2014-2957 10.4103/2230-8210.102995 10.1210/jc.2010-0917 10.1507/endocrj.51.601 10.1080/00015385.2019.1666964 10.1016/j.pharep.2019.01.014 10.1055/s-0035-1569375 10.1210/jcem.75.6.1464643 10.1159/000086363 10.1055/s-0034-1382048 10.1210/jcem.74.3.1311000 10.1055/s-0035-1549911 10.4158/EP151085.RA 10.1515/JPEM.2001.14.4.415 10.1210/jc.2014-1342 10.1159/000369901 10.1515/jpem-2016-0216 10.1210/jc.2018-00208 10.4158/EP-2019-0509 10.1007/s11136-019-02350-2 10.1007/s10508-006-9068-9 10.1007/s10508-016-0693-7 10.1016/j.jsxm.2015.11.002 10.1210/jc.2007-0556 10.1016/j.jsxm.2019.07.009 10.1016/j.psyneuen.2015.06.017 10.1210/js.2019-00122
Endocrine Ntali G, Charisis S et. al.

Apr 15th, 2021 - Females with NC21OHD may present as asymptomatic or develop a wide range of androgen excess expression. Clinical manifestations may become evident in childhood and adolescence and include premature pubarche, precocious puberty, acne, hirsutism, an...

Delayed Identification of Adolescent Adrenal Cortical Carcinoma Initially Diagnosed as ...
https://doi.org/10.1016/j.jpag.2021.03.004
Journal of Pediatric and Adolescent Gynecology; Ziqin L, Yurui W et. al.

Mar 29th, 2021 - Adrenocortical carcinoma is a rare, isolated malignancy. A 13-year-old girl presented with secondary amenorrhea, hirsutism, and hypertension. Her clinical manifestations were interpreted as polycystic ovary syndrome and hyperinsulinemia. The rapid...

Galanin and glypican-4 levels depending on metabolic and cardiovascular risk factors in...
https://doi.org/10.20945/2359-3997000000340
Archives of Endocrinology and Metabolism; Altinkaya SO

Mar 19th, 2021 - Galanin is a neuropeptide which has effects not only on metabolic syndrome but also on reproduction. Glypican-4 is an adipokine associated with insulin sensitivity by interacting directly with the insulin receptor. This study evaluated serum conce...

Ovarian Leydig cell tumor and postmenopausal hirsutism with signs of virilisation.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978078
BMJ Case Reports; Ferrinho C, Silva E et. al.

Mar 18th, 2021 - A 71-year-old woman was referred to the endocrinology clinic to investigate postmenopausal hirsutism with 10 years of evolution. She had history of regular menses and menopause with 50 years old. Physical examination showed a male pattern facies, ...

see more →

News  117 results

Increased Risk of Meningioma With Cyproterone Acetate Use
https://www.medscape.com/viewarticle/945218

Feb 2nd, 2021 - New details confirm an increased risk of developing intracranial meningiomas after prolonged use of the hormonal product cyproterone acetate. Cyproterone acetate is a synthetic progestogen and potent anti-androgen that has been used in the treatme...

Metformin Not Better Than Oral Contraceptive for Treating PCOS-Related Hirsutism
https://www.medscape.com/viewarticle/936850

Sep 7th, 2020 - NEW YORK (Reuters Health) - Metformin monotherapy might be less effective than oral contraceptive pills (OCPs) for treating hirsutism in women with polycystic ovary syndrome (PCOS), according to a new Cochrane review. In fact, "OCP alone or metfor...

GPs Need Better Education on All Symptoms of PCOS, Say Patients
https://www.medscape.com/viewarticle/927116

Mar 18th, 2020 - Women who have polycystic ovary syndrome (PCOS) often feel their general practitioners (GPs) trivialize the condition as only a fertility problem and do not discuss any of the other long-term health consequences, new results from a UK survey revea...

EU Restricts High-Dose Cyproterone Because of Meningioma Risk
https://www.medscape.com/viewarticle/925271

Feb 13th, 2020 - Cyproterone products with daily doses of 10 mg or more should be restricted because of a risk of developing meningioma, says the safety committee of the European Medicines Agency. Products containing cyproterone 10 mg daily or more should be used ...

Screening and Management of the Hyperandrogenic Adolescent
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Adolescent-Health-Care/Screening-and-Management-of-the-Hyperandrogenic-Adolescent

Sep 23rd, 2019 - Although androgen excess can manifest in many ways, the most common and recognizable symptoms are hirsutism and acne. Reports of hirsutism and acne should be taken seriously because of their possible association with medical disorders, their subst...

see more →

Patient Education  17 results see all →